Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

BTAI BioXcel Therapeutics Inc

0,3691

0,0022 (0,60%)

01 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

BioXcel Therapeutics (NASDAQ:BTAI)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more BioXcel Therapeutics Charts.

BioXcel Therapeutics (NASDAQ:BTAI)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more BioXcel Therapeutics Charts.

News BioXcel Therapeutics Inc

Form DEF 14A - Other definitive proxy statements
Montag 30 Dezember 2024 (2 Tage vor) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Mittwoch 18 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 18 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 18 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 18 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 16 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 16 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 16 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 25 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Montag 25 November 2024 (1 Monat vor) • Edgar (US Regulatory)

BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering
Freitag 22 November 2024 (1 Monat vor) • GlobeNewswire Inc.

BioXcel Therapeutics Announces Proposed Public Offering
Donnerstag 21 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Weitere BioXcel Therapeutics Inc News-Artikel

BNP Paribas (QX)

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen